Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed with results

Key Signals

4 with results92% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (8)
P 1 (1)

Trial Status

Completed11
Terminated1
Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (13)

Research Network

Activity Timeline